Horne, A. W., Vincent, K., Hewitt, C. A., Middleton, L. J., Koscielniak, M., Szubert, W., Doust, A. M., Daniels, J. P., , , Abdi, S., Acharya, S., Al-Inizi, S., Ball, E., Baranowski, A., Bhal, N., Bhatia, K., Bhattacharya, S., Birch, J. V., Carpenter, T., Chalhoub, T., Cheong, Y. C., Clark, T. J., Cregg, R., Dada, T. D., Datta, D., Faraj, R., Feltham, M. G., Gupta, P., Hapangama, D., Hardwick, C., Hughes, J., Khatri, P., Kumar, G., Leighton, L. J., Majumder, K., McFarlane, G. J., Mortimer, A., Odedra, S., Ramsay, B., Raza, A., Rea, W., Roy, S., Sajid, A., Saraswat, L., Shah, A., Sivasamy, J., Srivastava, R., Stubbs, C., Swaminathan, A., Thampi, P., Thanoon, O., Thomas, T., Tracey, I., Underwood, M., Willocks, C., Williams, A. C. d. C., Wood, S., & Zondervan, K. (2020). gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet, 396(10255), 909–917. http://access.bl.uk/ark:/81055/vdc_100110819586.0x000056